Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
15 Dec 2017 NICE Issues Technology Appraisal Guidance on Atezolizumab in Advanced Urothelial Cancer Genitourinary cancers - Cancer Immunology and Immunotherapy
12 Dec 2017 Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Advanced Hodgkin’s Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
13 Dec 2017 First-line Ribociclib Improves PFS in Pre- and Peri-menopausal Women with HR-positive, HER2-negative Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
11 Dec 2017 MMR Deficiency Screening is Under-utilised in Young Adult Patients with Colorectal Cancer Gastrointestinal cancers - Cancer in Special Situations
06 Dec 2017 FDA Approves Ogivri as a Biosimilar to Herceptin Breast cancer - Anticancer agents & Biologic therapy
05 Dec 2017 EMA Issues Warning About Use of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone or Prednisolone Genitourinary cancers - Anticancer agents & Biologic therapy
04 Dec 2017 FDA Grants Marketing Approval to FoundationOne CDx In Vitro Diagnostic Personalised medicine
29 Nov 2017 New EU Guidelines on Good Manufacturing Practices for Advanced Therapies Bioethics, legal and economic issues
28 Nov 2017 New EMA CHMP Guideline on the Evaluation of Anticancer Medicinal Products in Man Anticancer agents & Biologic therapy
27 Nov 2017 Withdrawal of the Marketing Authorisation Application for Biosimilar Bevacizumab (Kyomarc) Anticancer agents & Biologic therapy
24 Nov 2017 Withdrawal of the Application for a Change to the EU Marketing Authorisation for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
23 Nov 2017 FDA Approves Emicizumab-kxwh for Prevention and Reduction of Bleeding in Patients with Haemophilia A with Factor VIII Inhibitors Haematologic malignancies
20 Nov 2017 FDA Approves Sunitinib Malate for Adjuvant Treatment of RCC Genitourinary cancers - Anticancer agents & Biologic therapy
16 Nov 2017 EMA Recommends Extension of Indications for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
15 Nov 2017 FDA Grants Approval to Vemurafenib for Erdheim-Chester Disease Anticancer agents & Biologic therapy